Interim Director for the Division of Endocrinology
Medical Director of the Hallett Center for Diabetes and Endocrinology
Associate clinical staff member, Rhode Island Hospital, The Miriam Hospital, Providence VA Medical Center and Women & Infants Hospital
Associate professor of medicine, Warren Alpert Medical School of Brown University
Program director, clinical fellowship in endocrinology, diabetes and metabolism
MD, Texas A&M University Health Science Center, 1994 Board certified in internal medicine and endocrinology, diabetes, and metabolism
Geetha Gopalakrishnan, MD, has been appointed the Interim Director for the Division of Endocrinology and the Medical Director of the Hallett Center for Diabetes and Endocrinology effective July 1, 2011. Dr. Gopalakrishnan is an associate professor of medicine at the Alpert Medical School of Brown University and the director of clinical education for the division of endocrinology. In this capacity, Dr. Gopalakrishnan coordinates the educational programs for the division of endocrinology including the fellowship program in endocrinology, diabetes and metabolism. Her clinical and research activities focus on women's health topics like osteoporosis and pregnancy. She will continue to be the director of the bone health program at Women and Infants Hospital and the bone density program at the Women's Medicine Collaborative affiliated with The Miriam Hospital
Gopalakrishnan, joined the faculty in 2001 as assistant professor of medicine in the division of endocrinology, diabetes and metabolism. She graduated from Texas A&M University Health Science Center with a BS in basic medical science in 1992 and received her MD in 1994. After completing internal medicine residency training at Brown University, she subspecialized in endocrinology, diabetes, and metabolism at Stanford. She also obtained additional postdoctoral training in epidemiology and biostatistics from Stanford. Her honors include the Fogerty International Research and Training Fellowship from the International Health Institute at Brown University and the MSC Jordan Fellowship from Texas A&M University.
The focus of Gopalakrishnan's research is on HIV-related endocrinopathies as well as bone and mineral metabolism. She has participated in numerous studies evaluating risk factors for and treatment of osteoporosis, osteopenia, and hyperparathyroidism. She is currently coordinating studies to evaluate the bone complications of HIV-infection and treatment regimens. She also is developing trials on the prevention and treatment of osteoporosis in HIV infected individuals. Collaborating with the International Health Institute at Brown University and the Y.R. Gaitonde Center for AIDS Research and Education in Chennai, India, Gopalakrishnan is involved in studies evaluating endocrine complications of HIV.